Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

NAActive, not recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Multiple Myeloma
Interventions
OTHER

Continued treatment adapted to the response

Instead of receiving a pre-specified number of treatment cycles, regardless of the result obtained, in the MRDI-driven treatment group patients continue receiving treatment until reaching a complete remission with negative MRD and Image, changing the therapeutic line if it is not obtained with the line current therapy. In this group of the patients the treatment was stopped only when this degree of deep response was achieved.

All Listed Sponsors
lead

Hospital Galdakao-Usansolo

OTHER_GOV